Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000458676 | SCV000556150 | likely benign | Juvenile polyposis syndrome | 2023-08-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000614902 | SCV000720124 | likely benign | not specified | 2017-06-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000775647 | SCV000910027 | likely benign | Hereditary cancer-predisposing syndrome | 2017-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002383862 | SCV002693619 | likely benign | Familial thoracic aortic aneurysm and aortic dissection; Hereditary cancer-predisposing syndrome | 2021-02-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003418210 | SCV004143107 | likely benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | SMAD4: BP4 |